King Saud University Medical City
Sensory Cloud Announces Positive Results from the Phase 2 REACH Trial at King Saud University Medical City in Patients with Refractory Chronic Cough (RCC)
Daily treatment with SC0023 yielded treatment efficacy 53.5% ± 19.2% relative to baseline in 24-hour daily cough rate and 19.5% ± 6.2% placebo effect Cough rate reduction was observed from the first day of dosing and across baseline cough rates ranging from 5 to 25 coughs/hour Persistent cough suppression post-treatment was also observed across cough […]
Nour Elotaiby ·